MONOCLONAL-ANTIBODY PURIFIED FACTOR-IX - VIRAL SAFETY IN PUPS

被引：0
|
作者：
SHAPIRO, A
BERGMAN, GE
机构：
[1] JAMES WHITCOMB RILEY HOSP CHILDREN,INDIANAPOLIS,IN 46202
[2] ARMOUR PHARMACEUT CO,COLLEGEVILLE,PA
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A64 / A64
页数：1
相关论文
共 50 条
  • [31] MONOCLONAL-ANTIBODY TO AN EPITOPE ON THE HEAVY-CHAIN OF FACTOR-IX MISSING IN 3 HEMOPHILIA-B PATIENTS
    THOMPSON, AR
    BLOOD, 1983, 62 (05) : 1027 - 1034
  • [32] SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY-PURIFIED FACTOR-IX CONCENTRATE FOR MANAGEMENT OF BLEEDING AND SURGICAL PROPHYLAXIS IN PREVIOUSLY TREATED CHILDREN WITH HEMOPHILIA-B
    KURCZYNSKI, E
    LUSHER, JM
    PITEL, P
    SHAPIRO, AD
    BERGMAN, GE
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1995, 2 (03): : 211 - 216
  • [33] PROTEOLYTIC ACTIVATION OF PURIFIED HUMAN FACTOR-IX
    CHANDRA, S
    PECHET, L
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 226 - 226
  • [34] VIRAL SAFETY OF A NEW FACTOR-IX PREPARATION (OCTANINE-F)
    GARTNER, T
    SUHARTONO, H
    WANG, LR
    BREDE, HD
    BIESERT, L
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1021 - 1021
  • [35] FACTOR-IX CONCENTRATE AND VIRAL HEPATITIS
    BOKLAN, BF
    ANNALS OF INTERNAL MEDICINE, 1971, 74 (02) : 298 - +
  • [36] Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B
    Shapiro, AD
    Ragni, MV
    Lusher, JM
    Culbert, S
    Koerper, MA
    Bergman, GE
    Hannan, MM
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (01) : 30 - 35
  • [37] DISSEMINATED INTRAVASCULAR COAGULATION AFTER FACTOR-IX COMPLEX RESOLVED USING PURIFIED FACTOR-IX CONCENTRATE
    HADLEY, T
    DJULBEGOVIC, B
    ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 621 - 622
  • [38] DETERMINATION OF THE RELATIVE ACTIVITIES OF 2 FACTOR-IX VARIANTS - FACTOR-IX ALABAMA AND FACTOR-IX CHAPEL HILL - IN A PURIFIED FACTOR-X ACTIVATING SYSTEM
    BRIET, E
    GRIFFITH, MJ
    BRAUNSTEIN, KM
    ROBERTS, HR
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 656 - 656
  • [39] CHARACTERIZATION OF NANOTIV, A HIGHLY PURIFIED FACTOR-IX CONCENTRATE
    OSTLIN, A
    LOF, AL
    ERIKSSON, B
    MATTSON, C
    MOBERG, U
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1283 - 1283
  • [40] THE ROLE OF VITRONECTIN IN HIGHLY PURIFIED FACTOR-IX CONCENTRATES
    TORMA, E
    SUOMELA, H
    HAMALAINEN, E
    KRUSIUS, T
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1158 - 1158
12345